dapsone has been researched along with Lupus Erythematosus, Cutaneous in 31 studies
Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 7.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 3.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone was discontinued in 9 patients: in 4 due to reversible side effects and in 5 patients due to poor efficacy." | 2.53 | Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature. ( Aberer, E; Klebes, M; Wutte, N, 2016) |
| "The mainstays of treatment of cutaneous lupus erythematosus (LE) are topical and intralesional steroids, sunscreen, and the antimalarials." | 2.38 | Treatment of cutaneous lupus erythematosus. ( Kerdel, FA; Rothe, MJ, 1992) |
| "A treatment with dapsone was prescribed and yielded rapid improvement." | 1.56 | Scarring alopecia in chronic cutaneous lupus erythematosus with neutrophils: A new scenario with therapeutic connotations. ( Bello, JA; Cabo, F; Fernandez-Flores, A; Hermosa-Gelbard, A; Pérez, A, 2020) |
| "Vesico-bullous subacute cutaneous lupus erythematosus is an uncommon and severe presentation." | 1.38 | Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine. ( Alves, R; Pinto-Almeida, T; Sanches, M; Selores, M, 2012) |
| "Bullous systemic lupus erythematosus (BSLE) is a rare subset of systemic lupus erythematosus that is often associated with autoimmunity to type VII collagen." | 1.33 | Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. ( Fujimoto, W; Hamada, T; Iwatsuki, K; Matsuura, H; Yamada, J, 2005) |
| "We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies." | 1.30 | A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. ( Bernacchi, E; Bombardieri, S; Mosca, M; Neri, R, 1999) |
| "Treatment with prednisolone (15 mg/day), chloroquine phosphate (200 mg/ day), cyclosporine (5 mg/kg daily), and gold (10 mg/day) failed to reduce pruritic plaque formation, and pulse methylprednisolone therapy led to only a transient remission." | 1.29 | Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy. ( Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, H | 1 |
| Gudjonsson, JE | 1 |
| Kahlenberg, JM | 2 |
| Fernandez-Flores, A | 1 |
| Hermosa-Gelbard, A | 1 |
| Pérez, A | 1 |
| Bello, JA | 1 |
| Cabo, F | 1 |
| Nutan, F | 1 |
| Ortega-Loayza, AG | 1 |
| Hsieh, FN | 1 |
| Yu-Yun Lee, J | 1 |
| Zampeli, E | 1 |
| Moutsopoulos, HM | 1 |
| Klebes, M | 1 |
| Wutte, N | 1 |
| Aberer, E | 2 |
| Stannard, JN | 1 |
| Juhász, M | 1 |
| Rogge, M | 1 |
| Chen, M | 1 |
| Czernik, A | 1 |
| Jung Kim, S | 1 |
| Geller, L | 1 |
| Kuhn, A | 2 |
| Bata-Csörgő, Z | 1 |
| Caproni, M | 1 |
| Dreher, A | 1 |
| Frances, C | 2 |
| Gläser, R | 1 |
| Klötgen, HW | 1 |
| Landmann, A | 1 |
| Marinovic, B | 1 |
| Nyberg, F | 1 |
| Olteanu, R | 1 |
| Ranki, A | 1 |
| Szepietowski, JC | 1 |
| Volc-Platzer, B | 1 |
| Abe, M | 1 |
| Shimizu, A | 1 |
| Yokoyama, Y | 1 |
| Takeuchi, Y | 1 |
| Ishikawa, O | 1 |
| Renner, R | 1 |
| Sticherling, M | 1 |
| Ruland, V | 1 |
| Bonsmann, G | 1 |
| Chang, AY | 1 |
| Werth, VP | 1 |
| Al-Mutairi, N | 1 |
| Pinto-Almeida, T | 1 |
| Sanches, M | 1 |
| Alves, R | 1 |
| Selores, M | 1 |
| Barete, S | 1 |
| Ayoub, N | 1 |
| Piette, JC | 1 |
| Wenzel, J | 1 |
| Bieber, T | 1 |
| Uerlich, M | 1 |
| Tüting, T | 1 |
| Fujimoto, W | 1 |
| Hamada, T | 1 |
| Yamada, J | 1 |
| Matsuura, H | 1 |
| Iwatsuki, K | 1 |
| Callen, JP | 2 |
| Tsutsui, K | 1 |
| Imai, T | 1 |
| Hatta, N | 1 |
| Sakai, H | 1 |
| Takata, M | 1 |
| Takehara, K | 1 |
| Mok, CC | 2 |
| Lau, CS | 2 |
| Shuster, J | 1 |
| Wong, RW | 1 |
| Neri, R | 1 |
| Mosca, M | 1 |
| Bernacchi, E | 1 |
| Bombardieri, S | 1 |
| Christiansen, J | 1 |
| Tegner, E | 1 |
| Irestedt, M | 1 |
| Davies, MG | 1 |
| Newman, P | 1 |
| Rothe, MJ | 1 |
| Kerdel, FA | 1 |
| Pascual Velasco, F | 1 |
| Joubert, B | 1 |
| Devant, O | 1 |
| Amblard, P | 1 |
| Holtman, JH | 1 |
| Neustadt, DH | 1 |
| Klein, J | 1 |
| Rock, B | 1 |
| Patel, HP | 1 |
11 reviews available for dapsone and Lupus Erythematosus, Cutaneous
| Article | Year |
|---|---|
Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
Topics: Antibodies, Monoclonal; Dapsone; Humans; Hydroxychloroquine; Interferon Type I; Lupus Erythematosus, | 2020 |
Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimalarials; Calcineurin Inhibitors; Dapsone; Hum | 2017 |
Leukocytoclastic Vasculitis Concurrent With Bullous Systemic Lupus Erythematosus Manifesting Striking Wood-Grain and Wi-Fi Sign-like Purpuric Lesions.
Topics: Biopsy, Needle; Dapsone; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Male; Middle | 2019 |
Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature.
Topics: Adult; Aged; Aged, 80 and over; Antimalarials; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneo | 2016 |
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2016 |
The different faces of cutaneous lupus erythematosus.
Topics: Antimalarials; Azathioprine; Biomarkers; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug | 2009 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murin | 2011 |
Treatment of cutaneous lupus.
Topics: Administration, Topical; Antimalarials; Calcineurin Inhibitors; Dapsone; Glucocorticoids; Humans; Im | 2011 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimal | 2003 |
Treatment of cutaneous lesions in patients with lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antimalarials; Azathioprine; Combined Modality Therapy; Dapsone; Drug Thera | 1994 |
Treatment of cutaneous lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antimalarials; Dapsone; Drug Resistance; Humans; Immunosuppressive Agents; | 1992 |
20 other studies available for dapsone and Lupus Erythematosus, Cutaneous
| Article | Year |
|---|---|
Scarring alopecia in chronic cutaneous lupus erythematosus with neutrophils: A new scenario with therapeutic connotations.
Topics: Alopecia; Antimalarials; Autoimmune Diseases; Biopsy; Chronic Disease; Cicatrix; Dapsone; Diagnosis, | 2020 |
Dapsone: an old drug effective for subacute cutaneous lupus erythematosus.
Topics: Anti-Infective Agents; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged | 2019 |
Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous Immunoglobulin.
Topics: Adolescent; Dapsone; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Cutaneous; S | 2017 |
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Topics: Adrenal Cortex Hormones; Antimalarials; Biological Products; Calcineurin Inhibitors; Consensus; Daps | 2017 |
A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Dapsone; Depression, Chemical; Humans; Immunohisto | 2008 |
Nosology and therapeutic options for lupus miliaris disseminatus faciei.
Topics: Adult; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Lupus Erythematosus, C | 2011 |
Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
Topics: Antirheumatic Agents; Blister; Dapsone; Folic Acid Antagonists; Humans; Hydroxychloroquine; Lupus Er | 2012 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE.
Topics: Betamethasone; Biopsy, Needle; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, | 2005 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3 | 1996 |
Dapsone syndrome in cutaneous lupus erythematosus.
Topics: Adult; Dapsone; Fatal Outcome; Female; Humans; Leprostatic Agents; Lupus Erythematosus, Cutaneous; M | 1996 |
Dapsone and liver failure.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Monitoring; Humans; Liver Failure; Lupu | 1998 |
Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases.
Topics: Adolescent; Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Eryt | 1998 |
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Hum | 1999 |
Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Follow-Up Stu | 1999 |
Linear cutaneous lupus erythematosus in association with ipsilateral submandibular myoepithelial sialadenitis.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Female; | 2001 |
[Dapsone syndrome].
Topics: Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Erythematosus, Cutaneous; Syndrome | 1991 |
[Disulone: focus on its indications in dermatology].
Topics: Dapsone; Granuloma; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Syst | 1990 |
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; | 1990 |
Bullous eruption in a patient with lupus erythematosus.
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; Prednisone; Skin Diseases, Vesiculob | 1987 |